MedPath

石药集团巨石生物制药有限公司

Ownership
-
Established
2019-04-16
Employees
-
Market Cap
-
Website
www.e-cspc.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Omalizumab for Injection

Product Name
恩益坦
Approval Number
国药准字S20240043
Approval Date
Sep 26, 2024
NMPA

Enlonstobart Injection

Product Name
恩舒幸
Approval Number
国药准字S20240028
Approval Date
Jun 25, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.